Log In
person
Novartis AG
NVSEF
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (CHF) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (CHF) | Percentage |
| Blockchain |
Blockchain-Enabled Supply Chain Management for Pharmaceutical Companies
These companies provide a broad range of services that are centered around supplier selection for pharmaceutical companies.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| Revenues |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
45.44B | 100.00% |
| keyboard_arrow_down |
Blockchain
Blockchain-Enabled Supply Chain Management for Pharmaceutical Companies
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies provide a broad range of services that are centered around supplier selection for pharmaceutical companies.
|
||
| keyboard_arrow_down |
Revenues
Branded Pharmaceuticals
|
45.44B | 100.00% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||